Sarasota Memorial's Kolschowsky Research and Education Institute is enrolling eligible patients in a new clinical trial, testing whether an investigational drug could reduce heart attacks and mortality in individuals with a specific genetic variant following a sudden cardiac event.
Wednesday, September 17, 2025
Sarasota Memorial has been recognized for its commitment to innovation and use of health technology. Today Newsweek’s named SMH amongst its “World’s Best Smart Hospitals 2026.”
Wednesday, September 10, 2025
Today, Sarasota Memorial Health Care System and its Trauma & Acute Care Surgery Services Division were formally recognized by the U.S. Department of Defense’s Employer Support of the Guard and Reserve (ESGR) with two prestigious Seven Seals Awards, honoring the health system’s outstanding support of employees who serve in the U.S. Armed Forces Reserves and National Guard.
Tuesday, September 9, 2025
Sarasota Memorial’s thyroid and parathyroid specialist, Ralph P. Tufano, MD, MBA, FACS, in collaboration with the SMH Kolschowsky Research and Education Institute, is leading a multicenter clinical study to capture the clinical and quality of life benefits of a new ablation treatment for non-cancerous thyroid nodules.
Monday, September 8, 2025
Sarasota Memorial thyroid/parathyroid specialist Ralph P. Tufano, MD, MBA, FACS, has been recognized among a panel of leading medical experts who have issued new guidelines for the treatment of differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid.
Friday, September 5, 2025